MAX
Company Analysis Sinopharm Group Co., Ltd.
1. Summary
Advantages
- Price (2.35 $) is less than fair price (3.95 $)
- The stock's return over the last year (14.89%) is higher than the sector average (-11.03%).
- Current debt level 18.35% is below 100% and has decreased over 5 years from 20.98%.
Disadvantages
- Dividends (0%) are below the sector average (1.71%).
- The company's current efficiency (ROE=12.14%) is lower than the sector average (ROE=14.4%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Sinopharm Group Co., Ltd. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | -1.3% | -2.3% |
| 90 days | 5.9% | -23.4% | 1.4% |
| 1 year | 14.9% | -11% | 9.3% |
SHTDF vs Sector: Sinopharm Group Co., Ltd. has outperformed the "Healthcare" sector by 25.93% over the past year.
SHTDF vs Market: Sinopharm Group Co., Ltd. has outperformed the market by 5.63% over the past year.
Stable price: SHTDF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: SHTDF with weekly volatility of 0.29% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (2.35 $) is lower than the fair price (3.95 $).
Price significantly below the fair price: The current price (2.35 $) is 68.1% lower than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (6.22) is lower than that of the sector as a whole (40.85).
P/E vs Market: The company's P/E (6.22) is lower than that of the market as a whole (47.46).
5.2.1 P/E Similar companies
5.3. P/BV
P/BV vs Sector: The company's P/BV (0.47) is lower than that of the sector as a whole (3.58).
P/BV vs Market: The company's P/BV (0.47) is lower than that of the market as a whole (4.32).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (0.0943) is lower than that of the sector as a whole (3.91).
P/S vs Market: The company's P/S indicator (0.0943) is lower than that of the market as a whole (12.19).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (2.34) is lower than that of the sector as a whole (15.98).
EV/Ebitda vs Market: The company's EV/Ebitda (2.34) is lower than that of the market as a whole (25).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Rising and has grown by 3.34% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (3.34%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-42.73%).
6.4. ROE
ROE vs Sector: The company's ROE (12.14%) is lower than that of the sector as a whole (14.4%).
ROE vs Market: The company's ROE (12.14%) is lower than that of the market as a whole (50.36%).
6.6. ROA
ROA vs Sector: The company's ROA (2.36%) is lower than that of the sector as a whole (7.44%).
ROA vs Market: The company's ROA (2.36%) is lower than that of the market as a whole (35.31%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (8.01%) is lower than that of the sector as a whole (14.06%).
ROIC vs Market: The company's ROIC (8.01%) is lower than that of the market as a whole (10.89%).
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.71%.
8.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0% has been steadily paid over the past 7 years, DSI=0.71.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 2 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (28.26%) are at a comfortable level.
Based on sources: porti.ru
